BridgeMD
New treatment option for Peyronie Disease
Official title Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease
ClinicalTrials.gov ID: NCT07317297
What this study is testing
- What it's testing
- Investigation of the effectiveness of extracorporeal shock wave therapy in the treatment of Peyronie's disease.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65, men only. Healthy volunteers may be eligible.
You may be able to join if
- Male individuals aged 18-65 years.
- Having been diagnosed with Peyronie's Disease that has been stable (without increasing pain and curvature) for at least 6 months.
- Presence of palpable penile plaque.
You likely can't join if
- Acute inflammatory stage (painful, progressive)
- Having previously undergone surgery, needle therapy (e.g., Xiaflex), or Extracorporeal Shockwave Therapy for peyronie's disease.
- Uncontrolled diabetes, severe coagulopathy, or receiving anticoagulant therapy.
- History of penile cancer.
- Severe erectile dysfunction.
- Patients who are considered unable to comply with the study protocol or who cannot attend follow-up visits.
The study team makes the final eligibility decision.
Where it's taking place
- Baku, Azerbaijan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baku, Azerbaijan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.